Adeniyi Olagunju
@aeolagunju
Pharmacologist with special interest in pregnancy & lactation, long-acting medicines, organs-on-chips, LMICs. Leads the Perinatal Pharmacology Group.
ID:620375223
https://www.liverpool.ac.uk/celt/ 27-06-2012 19:55:52
1,1K Tweets
925 Followers
1,4K Following
An interesting article under this research topic by Kammala et al. has just been published. The authors explored the utility of microfluidic technology and simulation models in studying pharmacokinetics during pregnancy: frontiersin.org/articles/10.33…
Frontiers in Pharmacology
Mentors make a huge difference and I am very thankful for some wonderful people who continue to guide, encourage and inspire. Today David Back and I talked about life, pharmacology, family, faith and much more - really helpful perspectives in a busy season.
This is a really exciting new initiative at University of Liverpool - 5-year University of Liverpool Research Fellowships with a permanent position at the end, subject to meeting criteria. Open across all disciplines; closing date Oct 1st. Pls RT. liverpool.ac.uk/research/fello…
CELT is an academic-led centre, built upon the cutting edge research of our scientists from #Chemistry and #Pharmacology . Our team of investigators lead multiple transformational projects.
Find out about our groups and their innovative research projects👉liverpool.ac.uk/centre-of-exce…
🎉Time to celebrate LivUni School of Life Sciences graduates! As you embark on this new chapter, we wish you all the best for a bright and successful future. 🌟
#LivUniGrad #Classof2023
A University of Liverpool researcher, Dr Adeniyi Olagunju has been awarded a highly competitive fellowship, the Wellcome Career Development Award.
The £1.68m will allow Dr Olagunju to continue his research into drug safety in pregnancy.
Read more here news.liverpool.ac.uk/2023/07/06/1-6…
There is still time to submit your abstract for the #AntiviralPK workshop, which this year takes place in Rome, 11-13 Sep. I am particularly excited about the pregnancy and other understudied populations category. Don't miss your chance to share your research. Portal link below.
Approximately 75% of people living with #hepatitisC reside in low- and middle-income countries with millions having limited access to life-saving medication.
Learn how we aim to revolutionise #HepC healthcare for those in most need 👉liverpool.ac.uk/centre-of-exce…
#LONGEVITYProject
Absolutely delighted to welcome Dr Nicola Darling to Biochemistry, Cell and Systems Biology and Inst. of Systems, Molecular & Integrative Biology. Nicola has taken up an academic position as a Tenure Track Fellow in our department, where her research will explore the mysteries of signalling in mast cells. Great to have you with us Nicola!
📢The 5th ed. of the #LiverpoolCourse is coming to Rome!
Take advantage of the complimentary registration to join leading experts - explore fresh insights into the principles of clinical #pharmacology in an era of #polypharmacy .
Sign-up bit.ly/3CDaWw9
HIV Drug Interactions
📢📰 In the News today!! Highlighting the impact of delays in access on outcomes of pregnancy and childbirth for women and their babies. The Guardian Nigeria #maternalhealth #Newborn #Stillbirth #MaternalMortality #Delay #Nigeria #Africa #Equity Tackling In-transit delays 4 Mothers in Emergency guardian.ng/news/banke-tho…
Join #TeamLivUni and gain an MSc in Pharmacology and Toxicology. Apply now for September 2023!🔬🧬🧪🎓
Learn more: liverpool.ac.uk/systems-molecu…
#Therapeutics
#DrugSafety
#Nanomedicine
#DrugDevelopment
#Masters
Neill Liptrott
#PBPK workshop opened by Nada Abla Geiser from Medicines for Malaria Venture (MMV). Over the next 2 days, we focus on the application of #PBPK to antimalarials in pregnancy & lactation. Antimalarials primarily used in regions where breastfeeding is the norm Gates Foundation Certara #AtTheEquatorUG